|Articles|February 18, 2009

Treating CME with new gen NSAID

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%, from the January 2009 issue of Clinical Ophthalmology.

Please click here to read the full article.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Latest CME